Answers are grounded in this paper and cite their sources.
Variant analysis demonstrates optimization of antifungal properties of bacterial peptide EntV, highlighting potential strategies against fungal resistance.
Fungal resistance to commonly used medicines is a growing public health threat, and there is a dire need to develop new classes of antifungals. We previously described a peptide produced by
No takes yet. Share an insight, caveat, or question.
Guha et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: